Revvity
Kimchi Audrey Strasser is an accomplished professional in the field of biology with extensive experience in viral vector process development. Currently serving as Team Lead for viral vector process development at Revvity since May 2023, Kimchi has also held significant roles at SIRION BIOTECH GmbH since October 2017, where responsibilities have included Head of Process Development for viral vectors and previous experience as a Scientist in the AAV department. Earlier experience includes Biocurator at the Centre for Structural and Functional Genomics from May 2013 to September 2017. Kimchi holds a Doctor of Philosophy (PhD) degree in Biology from Concordia University, earned between 2004 and 2012.
This person is not in any teams
This person is not in any offices
Revvity
9 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com